ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ALBERTO COLOMER M.D.

Internal Medicine

650

$269K

110
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

73%
prescriptions for brand name drugs

Avg: 27%

$414
Average prescription price

Avg: $67

ROBERT MORRISON MD,PH.D

Internal Medicine

3,882

$1.58M

163
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

19%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

48%
prescriptions for brand name drugs

Avg: 27%

$406
Average prescription price

Avg: $67

GUS KRUCKE M.D.

Internal Medicine

6,039

$2.44M

294
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

53%
prescriptions for brand name drugs

Avg: 27%

$405
Average prescription price

Avg: $67

SABEEN NAJAM MD

Internal Medicine

2,888

$1.16M

399
240 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 27%

$400
Average prescription price

Avg: $67

AUNG NAING MD

Internal Medicine

477

$190K

80
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

58%
prescriptions for brand name drugs

Avg: 27%

$399
Average prescription price

Avg: $67

VIJAYA MURTHY MBBS

Internal Medicine

351

$140K

63
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 27%

$398
Average prescription price

Avg: $67

JUAN GARZA M.D.

Internal Medicine

3,016

$1.17M

179
79 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

55%
prescriptions for brand name drugs

Avg: 27%

$389
Average prescription price

Avg: $67

ARMANDO MEZA M.D.

Internal Medicine

1,263

$488K

58
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

57%
prescriptions for brand name drugs

Avg: 27%

$386
Average prescription price

Avg: $67

DAVID LEE MD

Internal Medicine

3,879

$1.43M

158
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

51%
prescriptions for brand name drugs

Avg: 27%

$369
Average prescription price

Avg: $67

DERRICK NGUYEN MD

Internal Medicine

717

$257K

69
50 are 65+

25%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 27%

$358
Average prescription price

Avg: $67

JAMES CARROLL MD

Internal Medicine

3,712

$1.33M

96
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

36%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

51%
prescriptions for brand name drugs

Avg: 27%

$358
Average prescription price

Avg: $67

BRADY ALLEN MD

Internal Medicine

3,326

$1.18M

120
48 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

33%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 27%

$354
Average prescription price

Avg: $67

STEPHEN RICHEY M.D., M.P.H

Internal Medicine

676

$237K

105
88 are 65+

29%
patients receiving schedule two controlled substances

Avg: 1%

23%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 27%

$350
Average prescription price

Avg: $67

STOCKTON ROBERTS DO

Internal Medicine

12,661

$4.39M

323
113 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

42%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

45%
prescriptions for brand name drugs

Avg: 27%

$346
Average prescription price

Avg: $67

NINA SHAH M.D.

Internal Medicine

378

$127K

47
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$336
Average prescription price

Avg: $67

STEVEN POUNDERS M.D.

Internal Medicine

3,970

$1.32M

129
58 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

33%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

45%
prescriptions for brand name drugs

Avg: 27%

$333
Average prescription price

Avg: $67

AMAL MELHEM-BERTRANDT M.D.

Internal Medicine

386

$126K

68
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 27%

$326
Average prescription price

Avg: $67

FERNANDO GARCIA M.D.

Internal Medicine

5,170

$1.67M

243
91 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

28%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 27%

$322
Average prescription price

Avg: $67

SUNIL PATEL M.D.

Internal Medicine

519

$167K

107
85 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$322
Average prescription price

Avg: $67

SATISH IDURU MD

Internal Medicine

893

$258K

256
175 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 15%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$289
Average prescription price

Avg: $67

PATRICK DALY M.D.

Internal Medicine

6,683

$1.88M

254
145 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

28%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 27%

$282
Average prescription price

Avg: $67

JANE AYALA M.D.

Internal Medicine

1,918

$532K

167
103 are 65+

11%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$278
Average prescription price

Avg: $67

AMIN ALOUSI M.D.

Internal Medicine

472

$126K

50
21 are 65+

26%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$267
Average prescription price

Avg: $67

LINSHENG GUO M.D.

Internal Medicine

704

$186K

99
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$264
Average prescription price

Avg: $67

PHILIP JOHNSON M.D.

Internal Medicine

5,246

$1.33M

324
185 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 27%

$254
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank